These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1438187)

  • 1. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
    Stura EA; Stanfield RL; Fieser GG; Silver S; Roguska M; Hincapie LM; Simmerman HK; Profy AT; Wilson IA
    Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies.
    Sharon M; Görlach M; Levy R; Hayek Y; Anglister J
    Protein Expr Purif; 2002 Apr; 24(3):374-83. PubMed ID: 11922753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody Fab fragment crystallized with and without a peptide epitope from HIV.
    Pfeffer-Hennig S; Wessner H; Hennig M; Dauter Z; Hausdorf G; Höhne WE
    Proteins; 1993 Aug; 16(4):437-9. PubMed ID: 7689218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
    Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
    J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
    Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
    Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide.
    Verdaguer N; Mateu MG; Bravo J; Tormo J; Giralt E; Andreu D; Domingo E; Fita I
    Proteins; 1994 Feb; 18(2):201-3. PubMed ID: 8159669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
    Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
    Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary crystallographic analysis of the Fab fragment of an antibody against HIV gp120.
    Vyas MN; Vyas NK; Liou RS; Chang TW; Quiocho FA
    J Mol Biol; 1990 Jul; 214(1):23-4. PubMed ID: 1695249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary crystallographic analysis of a Fab specific for P-glycoprotein with and without bound peptide.
    Vasudevan S; Johns KL; Rose DR
    J Mol Biol; 1994 Sep; 241(5):736-8. PubMed ID: 7915332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of streptococcal protein G in obtaining crystals of an antibody Fab fragment in complex with a meningococcal antigen.
    Derrick JP; Feavers I; Maiden MC
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):314-6. PubMed ID: 10089436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120.
    di Marzo Veronese F; Willis AE; Boyer-Thompson C; Appella E; Perham RN
    J Mol Biol; 1994 Oct; 243(2):167-72. PubMed ID: 7523682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the principal neutralization site of HIV-1.
    Ghiara JB; Stura EA; Stanfield RL; Profy AT; Wilson IA
    Science; 1994 Apr; 264(5155):82-5. PubMed ID: 7511253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
    Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
    J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
    Stanfield RL; Gorny MK; Williams C; Zolla-Pazner S; Wilson IA
    Structure; 2004 Feb; 12(2):193-204. PubMed ID: 14962380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary crystallographic studies of an anti-HIV-1 protease antibody that inhibits enzyme activity.
    Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
    Protein Sci; 1996 May; 5(5):966-8. PubMed ID: 8732768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal parameters and molecular replacement of an anticholera toxin peptide complex.
    Shoham M; Proctor P; Hughes D; Baldwin ET
    Proteins; 1991; 11(3):218-22. PubMed ID: 1749774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
    J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.